NHS Eyes Weight-Loss Jabs via Online Platforms to Tackle Obesity Crisis
The NHS is set to shake up the fight against obesity by potentially prescribing weight loss injections through online services. Digital platforms like Liva, Oviva, Roczen, and Second Nature could soon offer a lifeline to thousands struggling to shed pounds.
Virtual Clinics: Experts, Counselling and Jabs All in One
Draft guidance from the National Institute for Health and Care Excellence (Nice) recommends using these apps and websites to deliver weight management help. Patients will get access to dietitians, counsellors, and even prescriptions for injections like semaglutide (Wegovy) and liraglutide (Saxenda).
These treatments work alongside reduced-calorie diets and exercise plans, all managed from the comfort of home via computers or smartphones.
Cutting Waiting Lists and Expanding Care
Mark Chapman, interim director at Nice, blasted the current system’s shortcomings: “Waiting lists are long, some areas don’t have a service, and patients need a solution.” Online platforms are designed to plug this gap, easing pressure on hospital services and speeding up access.
Who Qualifies for Virtual Weight Loss Treatment?
- Must have a BMI of 35 or above
- One or more weight-related health issues, such as diabetes or high blood pressure
- Successful clinical assessment before starting treatment
Those who qualify could join a scheme benefiting up to 48,000 people nationwide, potentially freeing up 145,000 hours of clinician time, Nice says.
Big Pharma Study Sparks Hope
This push follows a five-year study from drug giant Novo Nordisk, which showed that Wegovy can cut heart attack and stroke risks by 20% in obese patients with cardiovascular disease. Though Wegovy has yet to launch in the UK, Nice gave it a nod earlier this year.
The NHS’s move to online weight-loss jabs signals a bold leap into digital healthcare—offering hope to thousands on long waiting lists desperate for help. Could this be the game-changer in Britain’s battle against obesity?
